CRISPR/Cas9Àº À¯ÀüÀÚ ÆíÁý ¹× ±â´É ºÐ¼®À» À§ÇÑ Çõ½ÅÀûÀÎ ±â¼ú·Î, ´ÙÄ«¶ó°¡ Á¦°øÇÏ´Â Guide-it¢â Á¦Ç°Àº º¸´Ù È¿À²ÀûÀÌ°í ¿ëÀÌÇÑ CRISPR À¯ÀüÀÚ ÆíÁý ½ÇÇèÀ» µµ¿Íµå¸³´Ï´Ù.
ÀÌ¹Ì ¸¹Àº °í°´µéÀÌ Guide-it¢â Á¦Ç°À» »ç¿ëÇÏ¿© ÁÁÀº ½ÇÇè µ¥ÀÌÅ͸¦ ¾ò¾ú´Âµ¥¿ä. ¿Ö ¿¬±¸ÀÚµéÀÌ Guide-it¢â CRISPR/Cas9 Á¦Ç°À» ¼±ÅÃÇß´ÂÁö ÇÔ²² º¸½ÃÁÒ!
1. Optimizing a screen for high-efficiency guide RNAs
Dr. Manabu Toyoshima (The Molecular Psychiatry team at the RIKEN Brain Science Institute)
Introduction
Manabu Toyoshima ¹Ú»ç´Â Á¶Çöº´°ú ¹ß´ÞÀå¾Ö ȯÀڷκÎÅÍ À¯·¡ÇÑ iPS ¼¼Æ÷¸¦ ÀÌ¿ëÇØ Áúº´ ¸ÞÄ¿´ÏÁò°ú ÀáÀçÀû Ä¡·á¹ýÀ» ±Ô¸íÇÏ°íÀÚ ÇÏ¿´´Ù. ÀÌ¿¡ Toyoshima ¹Ú»ç´Â °¡Àå ³ôÀº ÆíÁý
È¿À²À» °¡Áø single guide RNAs (sgRNAs)¸¦ ¼±º°Çϱâ À§ÇÏ¿© ´ç»çÀÇ
Guide-it¢â Complete sgRNA Screening SystemÀ» »ç¿ëÇÏ¿´´Ù.
Result
Human iPS ¼¼Æ÷ Áß ÇϳªÀÇ ¸ñÀû À¯ÀüÀÚ¸¦ Ÿ°ÙÇÏ´Â 5°³ÀÇ sgRNA¸¦ µðÀÚÀÎ ÈÄ,
Guide-it¢â Complete sgRNA Screening SystemÀ» ÀÌ¿ëÇÏ¿© °¢ sgRNAÀÇ Àý´Ü È¿À²À»
in vitro »ó¿¡¼ È®ÀÎÇÏ¿´´Ù. °á°ú¿¡ µû¶ó °¡Àå È¿À²ÀÌ ³ôÀº 2°³ÀÇ sgRNA (No. 2 & No. 4)¸¦
Human iPS ¼¼Æ÷ÀÇ CRISPR Knock-out ½ÇÇè¿¡ »ç¿ëÇÏ¿´´Ù. ¶ÇÇÑ »ý¼ºµÈ º¯ÀÌ (Mutagenesis)´Â ´ç»çÀÇ
Guide-it¢â Mutation Detection Kit·Î È®ÀÎÇÏ¿´´Ù.
±×¸² 1. Guide-it¢â Complete sgRNA Screening SystemÀ» ÀÌ¿ëÇÑ sgRNAÀÇ in vitro Àý´ÜÈ¿À².
sgRNA No.2¿Í No.4ÀÇ Àý´Ü È¿À²ÀÌ °¡Àå ³ôÀº °ÍÀ¸·Î È®ÀεǾúÀ¸¸ç, ÀÌ µÎ °³ÀÇ sgRNA¸¦ iPS ¼¼Æ÷ À¯ÀüÀÚ ÆíÁý¿¡ È°¿ëÇÏ¿´´Ù.
±×¸² 2. Human iPS ¼¼Æ÷¿¡¼ À¯ÀüÀÚ ÆíÁý È¿À².
Guide-it¢â Mutation Detection Kit¸¦ ÀÌ¿ëÇÏ¿© sgRNA No.2¿Í No.4ÀÇ À¯ÀüÀÚ ÆíÁý È¿À²À» È®ÀÎÇÏ¿´´Ù.
2. Electroporation of recombinant Cas9 in mouse embryos
Dr. Kazuki Nakao (University of Tokyo)
Introduction
Kazuki Nakao ¹Ú»ç´Â transgenic mouseÀÇ Ã¼¿Ü¼öÁ¤ (
In vitro fertilization, IVF)°ú ³Ãµ¿º¸Á¸¹ý (cryopreservation)À» ÁÖ·Î ¿¬±¸ÇÏ°í ÀÖ´Ù. Nakao ¹Ú»ç´Â ÃÖ±Ù,
´ÙÄ«¶ó¿¡¼ Á¦°øÇÏ´Â
Guide-it¢â Recombinant Cas9 (Electroporation-Ready)ÀÌ
Ÿ»çÀÇ Cas9 ´Ü¹éÁú¿¡ ºñÇÏ¿© ¼º´ÉÀÌ º¸´Ù ¿ì¼öÇÔÀ» Áõ¸íÇÏ´Â µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿´´Ù.
Result
C57BL/6N mouse ¹è¾Æ¿¡¼ tyrosinase locus ºÎÀ§¸¦ À¯ÀüÀÚ ÆíÁýÇϱâ À§ÇÏ¿©
Guide-it¢â Recombinant Cas9 (Electroporation-Ready)À» ÀÌ¿ëÇÏ¿© electroporation ÇÏ¿´´Ù. 14.5ÀÏ·ÉÀÇ mouse žƸ¦ »ç¿ëÇÏ¿´°í, tyrosinase locusÀÇ À¯ÀüÀÚ ÆíÁý ¼º°ø·üÀº ¾Ëºñ³ë
Ư¡À» º¸À̴ žÆÀÇ ¼ö·Î È®ÀÎÇÏ¿´´Ù.
Manufacturer |
Cas9
concentration
(ng/¥ìl) |
Number of embryos
subjected to
electroporation |
Number of implanted
electroporated
embryos |
Number
of fetuses |
Number of
albino
fetuses |
Takara Bio |
25 |
60 |
60 |
12 |
9 |
100 |
60 |
60 |
7 |
7 |
Company A |
25 |
60 |
60 |
13 |
2 |
100 |
60 |
60 |
23 |
12 |
400 |
40 |
40 |
7 |
4 |
Company B |
25 |
60 |
59 |
22 |
0 |
Ç¥ 1. Guide-it¢â Recombinant Cas9 (Electroporation-Ready)°ú Ÿ »çÀÇ Cas9 ´Ü¹éÁúÀ» ÀÌ¿ëÇÑ tyrosinase À¯ÀüÀÚ ÆíÁýÀÇ °á°ú.
Takara BioÀÇ Guide-it¢â Recombinant Cas9Àº Ÿ»ç Á¦Ç°¿¡ ºñÇØ ³·Àº ±Û¸®¼¼·Ñ ³óµµ¸¦ º¸À¯ÇÏ°í ÀÖ¾î ¼¼Æ÷ µ¶¼ºÀÌ ³·À» »Ó¸¸ ¾Æ´Ï¶ó ³ôÀº À¯ÀüÀÚ ÆíÁý È¿À²À» º¸ÀδÙ.
Guide-it¢â Recombinant Cas9ÀÇ À¯ÀüÀÚ ÆíÁý ¼º°ø·üÀº 25 ng/§¡ Cas9À» µµÀÔÇßÀ» ¶§ 75%, 100ng/§¡ Cas9À» µµÀÔÇßÀ» ¶§ 100%¸¦ º¸¿´´Ù. ÀÌ´Â A»çÀÇ Á¦Ç°, B»çÀÇ Á¦Ç°À»
»ç¿ëÇÏ¿´À» ¶§º¸´Ù ¿ùµîÈ÷ ³ôÀº À¯ÀüÀÚ ÆíÁý È¿À²ÀÓÀ» È®ÀÎÇÏ¿´´Ù. (A»ç Á¦Ç°ÀÇ À¯ÀüÀÚ ÆíÁýÈ¿À²: 15%, 52%, 57% / B»ç Á¦Ç°ÀÇ À¯ÀüÀÚ ÆíÁýÈ¿À²: 0%)
3. Microinjection of recombinant Cas9 in mouse embryos
Introduction
Result
C57BL/6 mouse embryo¿¡
Guide-it¢â Recombinant Cas9 (Electroporation-Ready)¿Í
donor construct (Ç¥ 2 ÂüÁ¶)¸¦ microinjectionÇÏ¿© À¯ÀüÀÚ ÆíÁýÀ» À¯µµÇÏ¿´´Ù. À¯ÀüÀÚÆíÁýÀÇ ¼º°øÈ®·üÀº µµÀÔÇÑ À¯ÀüÀÚ¸¦ º¸À¯ÇÏ°í
ÀÖ´Â »õ³¢ÀÇ ºñÀ²·Î È®ÀÎÇÏ¿´´Ù.
Gene
name |
Type
(insertion cassette/deletion length) |
Donor |
Litter size |
Pups containing
modification |
Efficiency |
Gene A |
Insert (length: 3 kb) |
Plasmid |
9 |
4 |
44% |
Gene B |
Insert (length: 7.5 kb) |
Plasmid |
11 |
4 |
36% |
Gene C |
Knockout (deletion length: 51 kb) |
Oligo DNA donor |
14 |
4 |
28% |
Gene D |
SNP |
Oligo DNA donor |
8 |
2 |
25% |
Gene E |
Flox |
Plasmid |
6 |
2 |
33% |
Gene F |
Flox |
Plasmid |
8 |
2 |
25% |